Alvotech (ALVO) Shares Outstanding (2020 - 2026)
Alvotech's (ALVO) quarterly Shares Outstanding (Entity) came in at $294.3 million in Q1 2026, down 5.68% on a QoQ basis from $312.0 million in Q4 2025.
Alvotech (ALVO) Shares Outstanding (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has 7 years of Shares Outstanding (Entity) data on file, last reported at $294.3 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) changed N/A year-over-year to $294.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $294.3 million (changed N/A YoY) and the FY2025 annual result came in at $312.0 million, up 3.38% from the prior year.
- Shares Outstanding (Entity) fell to $294.3 million in Q1 2026, from $312.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $312.0 million in Q4 2025 to a low of $181.7 million in Q2 2022.
- A 5-year average of $267.9 million and a median of $279.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) jumped 78.65% — and 2025, when it gained 3.38%.
- Tracing ALVO's Shares Outstanding (Entity) over 5 years: stood at $197.7 million in 2022, then jumped by 34.95% to $266.8 million in 2023, then increased by 13.11% to $301.8 million in 2024, then climbed by 3.38% to $312.0 million in 2025, then dropped by 5.68% to $294.3 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $294.3 million (Q1 2026), $312.0 million (Q4 2025), and $311.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 832.44 Mn |
| 10 | Alvotech | 1.30 Bn | 1.30 Bn | 5.09 Mn | 294.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 294.30 Mn |
| Dec 31, 2025 | 289.73 Mn |
| Sep 30, 2025 | 285.52 Mn |
| Jun 30, 2025 | 285.52 Mn |
| Mar 31, 2025 | 267.92 Mn |
| Dec 31, 2024 | 267.92 Mn |
| Sep 30, 2024 | 252.22 Mn |
| Jun 30, 2024 | 252.22 Mn |
| Mar 31, 2024 | 227.26 Mn |
| Dec 31, 2023 | 227.26 Mn |
| Aug 31, 2023 | 225.52 Mn |
| Jun 30, 2023 | 225.52 Mn |
| Mar 31, 2023 | 197.72 Mn |
| Dec 31, 2022 | 197.72 Mn |
| Aug 31, 2022 | 181.70 Mn |
| Jun 30, 2022 | 181.70 Mn |
| Mar 31, 2022 | 110.67 Mn |
| Dec 31, 2021 | 110.67 Mn |
| Sep 30, 2021 | 93.65 Mn |
| Dec 31, 2020 | 93.65 Mn |